Brief: SK Biopharmaceuticals says Co And Ono Pharmaceutical Enter Licensing Agreement For Cenobamate In Japan

SK Biopharmaceuticals Co

13/10/2020 14:18

Oct 13 (Reuters) - SK Biopharmaceuticals Co Ltd  326030.KS :
    * SK BIOPHARMACEUTICALS, ONO PHARMACEUTICAL ENTER LICENSING
AGREEMENT FOR CENOBAMATE IN JAPAN
    * SK BIOPHARMACEUTICALS CO LTD - CO, ONO PHARMACEUTICAL
COLLABORATE TO DEVELOP AND COMMERCIALIZE CENOBAMATE
    * SK BIOPHARMACEUTICALS CO LTD - SK BIOPHARMACEUTICALS TO
RECEIVE
AN UPFRONT PAYMENT OF JPY 5 BILLION FROM ONO
    * SK BIOPHARMACEUTICALS - SK BIOPHARMACEUTICALS TO RECEIVE
FUTURE
MILESTONES OF UP TO JPY 48.1 BILLION, ROYALTIES ON NET SALES
FROM ONO
    * SK BIOPHARMACEUTICALS - WILL CONDUCT PHASE 3 CLINICAL
STUDY FOR
PARTIAL-ONSET SEIZURES IN ADULTS IN NORTHEAST ASIA

Source text for Eikon:  ID:nPn9pKwSla 
Further company coverage:  326030.KS 

 ((Reuters.Briefs@thomsonreuters.com;))